Author

Nicole Farfán

Institut d'Investigació Biomédica de Bellvitge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adriana Rojas· 1 shared Aida Llucià ValldeperasiD· 1 shared Alexandre DeberiD· 1 shared Andrew Acevedo· 1 shared Aramis Cortes-Arias· 1 shared Bharath K. SampadiiD· 1 shared Christiaan H. ArendzeniD· 1 shared Christian Freund· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Adriana Rojas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Deletion of the MALAT1 RNA 3' end Promotes Transcript Decay and Inhibits Proliferation in Gastric and Breast Cancer Cells

Aramis Cortes-Arias, Valeria Valdes, Marcelo Muñoz-González, Diego Leiva, Andrew Acevedo, Michelle Tobar-Lara, Nicole Farfán, Lilly Oni, Eduardo Quiñones‐Medina, Verónica A. Burzio, Adriana Rojas, Roberto Munita, Srinivas Somarowthu, Fernando J. Bustos, Rodrigo Aguilar

This study shows that deleting the 3' end of MALAT1 RNA reduces its stability and inhibits cancer cell proliferation in gastric and breast cancer models.

International Journal of Biological Macromolecules · Aug 25, 2026Peer-reviewedMolecular Biology

Multi-omics reveals global signaling rewiring and identifies Activin A-induced dysregulation of FOS/Activator Protein 1 as a novel target in Fibrodysplasia ossificans progressiva

Marius Wits, Nerea Gomez-Suarez, Alexandre Deber, Nicole Farfán, Fjodor T. Bekedam, Bharath K. Sampadi, Sarah A. Rotman, Daniel Rubiera López, Judit Bestilleiro Márquez, Christiaan H. Arendzen, Christian Freund, Peter A. van Veelen, Aida Llucià Valldeperas, Frances S. de Man, Francesc Ventura, , Gonzalo Sánchez‐Duffhues

The paper uses multi-omics analyses to identify signaling dysregulation in FOP, highlighting AP-1 as a novel therapeutic target.

bioRxiv · Jan 21, 2025 · PreprintMolecular Biology